MedPath

Comparison Between Sonic Fill and X-tra Fill in Clinical Performance

Not Applicable
Completed
Conditions
SonicFill Clinical Performance
Sonicated Bulk-fill Resin Composite
Interventions
Other: bulk-fill composite resin restorations
Registration Number
NCT04926883
Lead Sponsor
Minia University
Brief Summary

The present study aims to evaluate a 2-years clinical performance of sonic-activated bulk-fill resin composite material (sonic fill) in comparison to conventional bulk-fill resin composite (X-tra fill) as posterior restorations. The null hypothesis is that sonic-activated bulk-fill resin composite restoration shows no difference when compared to conventional bulk-fill resin composite in clinical performance over 2-years evaluations based on clinical assessment.

Detailed Description

Restorations will be evaluated 1 week after placement (Baseline - T0), 3 months (T1), 6 months (T2), 1-year (T3) and 2-years (T4) of clinical service by blinded calibrated examiner using modified United States Public Health Service (USPHS) criteria where score A (Alpha) stands for the clinically ideal restoration. Score B (Bravo) is a clinically acceptable situation except for secondary caries. Score C (Charlie) indicates clinically unacceptable restorations that must be replaced.

The restorations will also be evaluated using revised FDI criteria with five grades for each criterion; scores 1 to 3 indicated clinically acceptable restorations, and scores 4 and 5 summarized clinically unacceptable situations indicating repair (score 4) or replacement (score 5).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • They should have an acceptable oral hygiene level.

    • Presence of at least two posterior carious lesions to be restored with two different types of composite.
    • The two materials should be used in approximately the same sized lesions or within the same extension.
    • Age range between 18 and 45 years.
    • A good likelihood of recall availability.
Exclusion Criteria
  • Severe or active periodontal or carious disease.
  • Heavy bruxism or a traumatic occlusion.
  • Patients with a compromised medical history or had received therapeutic irradiation to the head and neck region.
  • Alcoholic and smoker patients.
  • Patients had participated in a clinical trial within 6 months before commencement of this trial.
  • Patients unable to return for recall appointment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
X-tra fillbulk-fill composite resin restorations-
Sonic fillbulk-fill composite resin restorations-
Primary Outcome Measures
NameTimeMethod
change in clinical performance1 week, 3 months, 6 months, 12 months

restorations' evaluation for retention, color matching, marginal discoloration, marginal adaptation, secondary caries, surface texture, anatomic form.

Score A (Alpha) stands for the clinically ideal restoration. Score B (Bravo) is a clinically acceptable situation except for secondary caries. Score C (Charlie) indicates clinically unacceptable restorations that must be replaced. Also will be scored from 1 to 5 , which 1 to 3 indicated clinically acceptable restorations, and scores 4 and 5 summarized clinically unacceptable situations indicating repair (score 4) or replacement (score 5).

Secondary Outcome Measures
NameTimeMethod
change in post-operative pain using modified Visual Analogue Scale (VAS)daily for 1 week

The patients will be asked to record their pain level on modified Visual Analogue Scale (VAS) from 0 to 10, where 10 means sever pain, for 1 week.

Trial Locations

Locations (1)

Minia University

🇪🇬

Minya, Egypt

© Copyright 2025. All Rights Reserved by MedPath